Artificial intelligence is becoming more of the norm when it comes to cancer diagnosis. Dr. Babu Guda is a Professor of Biotechnology in the Department of Genetics at the University of Nebraska Medical Center’s Buffett Cancer Center and Eppley Institute and says this will be a valuable tool in determining a treatment plan.
Dr. Guda says, “Cancer is a constellation of diseases. It is a unique combination of genetic mutations in each patient. These mutations evolve over a period of time so artificial intelligence can shift through large volumes of health data from thousands of patients to identify unique mutations and this information can be objectively used to build models predicting the growth and spurt of cancer.”
Dr. Guda says the mutations are the key in any cancer. Mutations follow a random process so the mutations can on different paths in different patients. The earlier they can diagnose a cancer the better chances of survival.
Dr. Guda says they have been using A-I technology for research purposes for quite some time but it is not yet used for clinical purposes. He says this is still a very new theory and it will take a while to harness that technology at is evolves.